Roberts, J., Tenaglia, A., Bellissimo, E., & Kim, H. (2024). Treatment of oromandibular dystonia with botulinum toxin A improves apnea in a teenager with quadriplegic cerebral palsy: A case report. Journal of Pediatric Rehabilitation Medicine, 17(1), 125–129. https://doi.org/10.3233/prm-220105

Doruk, C., & Pitman, M. J. (2023). Lateral Transcervical In‐office Botulinum Toxin Injection for Retrograde Cricopharyngeal Dysfunction. The Laryngoscope, 134(1), 283–286. Portico. https://doi.org/10.1002/lary.30871

Shapiro, K., Anger, J., Cameron, A. P., Chung, D., Daignault‐Newton, S., Ippolito, G. M., Lee, U., Mourtzinos, A., Padmanabhan, P., Smith, A. L., Suskind, A. M., Tenggardjaja, C., Van Til, M., & Brucker, B. M. (2023). Antibiotic use, best practice statement adherence, and UTI rate for intradetrusor onabotulinumtoxin‐A injection for overactive bladder: A multi‐institutional collaboration from the SUFU Research Network (SURN). Neurourology and Urodynamics, 43(2), 407–414. Portico. https://doi.org/10.1002/nau.25334

Gormley, M., Chambers, H. G., Kim, H., Leon, J., Dimitrova, R., & Brin, M. F. (2023). Treatment of pediatric spasticity, including children with cerebral palsy, with Botox (onabotulinumtoxinA): Development, insights, and impact. Medicine, 102(S1), e32363. https://doi.org/10.1097/md.0000000000032363

Carruthers, J., Carruthers, A., Blitzer, A., Eadie, N., & Brin, M. F. (2023). Treatment of glabellar lines with Botox (onabotulinumtoxinA): Development, insights, and impact. Medicine, 102(S1), e32375. https://doi.org/10.1097/md.0000000000032375

Brin, M. F., & Blitzer, A. (2023). The pluripotential evolution and journey of Botox (onabotulinumtoxinA). Medicine, 102(S1), e32373. https://doi.org/10.1097/md.0000000000032373

Kohli, N., Lerner, M., Rashty, J., Kirke, D., Stewart, T., & Blitzer, A. (2022). IncobotulinimtoxinA (Xeomin) for the treatment of adductor laryngeal dystonia: A prospective, open-label clinical trial. American Journal of Otolaryngology, 43(6), 103613. https://doi.org/10.1016/j.amjoto.2022.103613

Reyes, F. I., Shoval, H. A., Tenaglia, A., & Kim, H. (2022). Ultrasound-Guided OnabotulinumtoxinA Injections to Treat Oromandibular Dystonia in Cerebral Palsy. Toxins, 14(3), 158. https://doi.org/10.3390/toxins14030158

Reynolds, W. S., Suskind, A. M., Anger, J. T., Brucker, B. M., Cameron, A. P., Chung, D. E., Daignault‐Newton, S., Lane, G. I., Lucioni, A., Mourtzinos, A. P., Padmanabhan, P., Reyblat, P. X., Smith, A. L., Tenggardjaja, C. F., & Lee, U. J. (2022). Incomplete bladder emptying and urinary tract infections after botulinum toxin injection for overactive bladder: Multi‐institutional collaboration from the SUFU research network. Neurourology and Urodynamics, 41(2), 662–671. Portico. https://doi.org/10.1002/nau.24871

Dimitrova, R., Kim, H., Meilahn, J., Chambers, H. G., Racette, B. A., Bonikowski, M., Park, E. S., McCusker, E., Liu, C., & Brin, M. F. (2022). Efficacy and safety of onabotulinumtoxinA with standardized physiotherapy for the treatment of pediatric lower limb spasticity: A randomized, placebo-controlled, phase III clinical trial. NeuroRehabilitation, 50(1), 33–46. https://doi.org/10.3233/nre-210070

Kim, H., & Kolaski, K. (2021). Is botulinum toxin type A more effective and safer than other treatments for the management of lower limb spasticity in children with cerebral palsy? A Cochrane Review summary with commentary. NeuroRehabilitation, 49(1), 161–164. https://doi.org/10.3233/nre-218003